WHO has granted the first prequalification listing of a bundle of three diagnostics tests to be used for pregnant women for the qualitative detection of HIV, Hepatitis B Surface Antigen, and Trepon

Rifampicin form I (WHOAPI-521) manufactured by Hebei Xingang Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

• TB409 Linezolid 150mg dispersible - Lupin Limited – INDIA

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

The In Vitro Diagnostics Assessment Team has published the Q2 2025 Newsletter summarizing the main news. 

You can access the New

We have been informed that, as part of the implementation of the

All applicants should note that all post PQ and EUL Change Request applications must now be submitted exclusively via the

The third assessment session for in vitro diagnostics in 2025 took place from 16 to 20 June 2025 in a fully virtual format.